OptimizeRx (OPRX) Non-Current Assets (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Non-Current Assets data on file, last reported at $111.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 4.27% year-over-year to $111.1 million; the trailing twelve-month figure through Mar 2026 stood at $452.5 million (down 5.43% YoY), and the FY2025 full-year result was $112.2 million, down 4.26% from the prior year.
• Non-Current Assets eased to $111.1 million in Q1 2026, from $112.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $129.0 million in Q4 2023 to a low of $25.4 million in Q1 2022.
• A 5-year average of $84.2 million and a median of $112.2 million in 2025 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets soared 257.71% in 2023 and retreated 9.34% in 2025, its largest moves.
• Tracing OPRX's Non-Current Assets over 5 years: stood at $36.1 million in 2022, then soared by 257.71% to $129.0 million in 2023, then slipped by 9.18% to $117.2 million in 2024, then dropped by 4.26% to $112.2 million in 2025, then declined by 0.98% to $111.1 million in 2026.
• Business Quant data shows OPRX's Non-Current Assets at $111.1 million in Q1 2026, $112.2 million in Q4 2025, and $114.0 million in Q3 2025.